IDSA’s “Science Speaks”: Study finds more than half of patients worldwide don’t access HIV treatment until immune systems are severely compromised
Antigone Barton, senior editor and writer of “Science Speaks,” discusses findings from a study published in Clinical Infectious Diseases on global trends in CD4 count at the start of antiretroviral therapy, writing, “Data from nearly a million patients starting treatment for HIV across the world over the last decade shows 55 percent of them accessed antiretroviral treatment only after their immune cell — or CD4 — counts had dropped below 200, leaving them extremely vulnerable to illnesses and infections” (2/1).